Micralyne Builds on Success in the Asian Market
News Mar 09, 2006
Micralyne Inc. has reported success penetrating the emerging MEMS market in Asia. Building on its position as one of the largest independent MEMS foundries in North America, Micralyne has extended its reach to Asia by serving companies in Japan and China.
While only active in Japan for three years, over 10% of Micralyne’s revenue now comes from that market. Due to Japan’s vast industrial base, even more growth is expected in the coming years.
In particular, the country’s massive automotive, industrial control and telecommunications industries are all expected to drive demand for MEMS-based components.
Many aspects of Micralyne’s success in Japan can be attributed to its partnership with Adamant Kogyo Co. Ltd.
"Micralyne’s relationship with Adamant has allowed us to bridge the communication and cultural barriers that sometimes arise between companies operating both in Japan and North America," stated Chris Lumb, President and CEO of Micralyne.
"Partnering with Adamant has proven to be an excellent strategy as we were able to bypass these challenges from the beginning. We look forward to further expanding our business in Japan and building an even stronger relationship with Adamant."
"We are pleased to be Micralyne’s representative in Asia," said Mr. Ryuichi Furuichi, President of Adamant.
"We see tremendous growth opportunities in Japan and the Micralyne-Adamant partnership allows us to offer the most effective solution for customers requiring development and volume manufacturing of MEMS-based products."
Micralyne is also serving emerging companies in China. Both China and Taiwan are projected to be significant and growing sources of revenue for Micralyne in the next three to five years.
This growth is being driven by the emerging industrial and consumer base in China as well as the demand for MEMS in next generation telecommunications and consumer electronics products.
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE
Making Drug Microparticles a Thousand Times FasterNews
Pharmaceuticals owe their effects mostly to their chemical composition, but the packaging of these drugs into specific physical formulations also need to be done to exact specifications. Engineers have now developed a microfluidic system where more than ten thousand devices run in parallel, all on a silicon-and-glass chip that can fit into a shirt pocket.READ MORE